Pulmonx (LUNG) Return on Sales (2019 - 2025)

Pulmonx (LUNG) has 7 years of Return on Sales data on file, last reported at 0.01% in Q3 2025.

• Return on Sales for Q3 2025 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.01% (changed 0.0% YoY), and the FY2024 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Sales retreated to 0.01% in Q3 2025 per LUNG's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Sales peaked at 0.01% in Q4 2024 and troughed at 0.01% in Q1 2022.
• A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Sales.
• On a YoY basis, Return on Sales climbed as much as 2 bps in 2021 and fell as far as 1 bps in 2021.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then advanced by 2 bps to 0.01% in 2022, then rose by 22 bps to 0.01% in 2023, then increased by 23 bps to 0.01% in 2024, then slipped by 17 bps to 0.01% in 2025.
• Business Quant data shows LUNG's Return on Sales at 0.01% in Q3 2025, 0.01% in Q2 2025, and 0.01% in Q1 2025.